3-Quinuclidinyl benzilate
3-Quinuclidinyl benzilate (pronunciation: 3-kwin-yoo-kli-din-yl ben-zil-ate), also known as QNB or BZ, is a potent anticholinergic agent.
Etymology
The name "3-Quinuclidinyl benzilate" is derived from its chemical structure, which consists of a quinuclidine core and a benzilate group. The "3-" prefix indicates the position of the benzilate group on the quinuclidine ring.
Pharmacology
3-Quinuclidinyl benzilate is classified as an anticholinergic compound, meaning it inhibits the action of the neurotransmitter acetylcholine at its receptor sites in the brain. This results in a variety of physiological effects, including dilated pupils, increased heart rate, and reduced salivation and perspiration.
Medical Use
3-Quinuclidinyl benzilate has been used in the past as a psychoactive drug due to its ability to induce delirium and hallucinations. However, its use in this context is highly controversial due to the potential for severe side effects and long-term damage.
Related Terms
See Also
External links
- Medical encyclopedia article on 3-Quinuclidinyl benzilate
- Wikipedia's article - 3-Quinuclidinyl benzilate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski